Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Ibrutinib for the treatment of chronic graft-vs-host disease in pediatric hematopoietic stem cell transplant patients: A single-center experience.

Teusink-Cross A, Davies SM, Grimley MS, Chandra S, Flannery A, Dandoy CE, Nelson AS, Marsh RA, Jacoby B, Lane A, Khandelwal P.

Pediatr Transplant. 2020 Mar 23:e13692. doi: 10.1111/petr.13692. [Epub ahead of print]

PMID:
32202691
2.

Patient iPSC-Derived Macrophages to Study Inborn Errors of the IFN-γ Responsive Pathway.

Haake K, Neehus AL, Buchegger T, Kühnel MP, Blank P, Philipp F, Oleaga-Quintas C, Schulz A, Grimley M, Goethe R, Jonigk D, Kalinke U, Boisson-Dupuis S, Casanova JL, Bustamante J, Lachmann N.

Cells. 2020 Feb 19;9(2). pii: E483. doi: 10.3390/cells9020483.

3.

High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy.

Lee LH, Krupski C, Clark J, Wunderlich M, Lorsbach RB, Grimley MS, Burwinkel M, Nelson A, Kumar AR.

Blood Adv. 2020 Feb 25;4(4):717-727. doi: 10.1182/bloodadvances.2019032367.

4.

EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects.

Rubinstein JD, Burns K, Absalon M, Lutzko C, Leemhuis T, Chandra S, Hanley PJ, Keller MD, Davies SM, Nelson A, Grimley M.

Pediatr Blood Cancer. 2020 Mar;67(3):e28126. doi: 10.1002/pbc.28126. Epub 2019 Dec 18.

PMID:
31850668
5.

CD38brightCD8+ T Cells Associated with the Development of Acute GVHD Are Activated, Proliferating, and Cytotoxic Trafficking Cells.

Khandelwal P, Chaturvedi V, Owsley E, Lane A, Heyenbruch D, Lutzko CM, Leemhuis T, Grimley MS, Nelson AS, Davies SM, Jordan MB, Marsh RA.

Biol Blood Marrow Transplant. 2020 Jan;26(1):1-6. doi: 10.1016/j.bbmt.2019.08.008. Epub 2019 Aug 20.

PMID:
31442594
6.

Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1β inhibition.

Gernez Y, de Jesus AA, Alsaleem H, Macaubas C, Roy A, Lovell D, Jagadeesh KA, Alehashemi S, Erdman L, Grimley M, Talarico S, Bacchetta R, Lewis DB, Canna SW, Laxer RM, Mellins ED, Goldbach-Mansky R, Weinacht KG.

J Allergy Clin Immunol. 2019 Oct;144(4):1122-1125.e6. doi: 10.1016/j.jaci.2019.06.017. Epub 2019 Jul 2. No abstract available.

PMID:
31271789
7.

Comparing a Neutropenic Diet to a Food Safety-Based Diet in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation.

Taggart C, Neumann N, Alonso PB, Lane A, Pate A, Stegman A, Stendahl A, Davies SM, Dandoy CE, Grimley M.

Biol Blood Marrow Transplant. 2019 Jul;25(7):1382-1386. doi: 10.1016/j.bbmt.2019.03.017. Epub 2019 Mar 22.

PMID:
30910605
8.

Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry.

Walkup LL, Myers K, El-Bietar J, Nelson A, Willmering MM, Grimley M, Davies SM, Towe C, Woods JC.

Eur Respir J. 2019 May 2;53(5). pii: 1801779. doi: 10.1183/13993003.01779-2018. Print 2019 May.

9.

Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients.

Bhatt ST, Bednarski JJ, Berg J, Trinkaus K, Murray L, Hayashi R, Schulz G, Hente M, Grimley M, Chan KW, Kamani N, Jacobsohn D, Nieder M, Hale G, Yu L, Adams R, Dalal J, Pulsipher MA, Haut P, Chaudhury S, Davis J, Jaroscak J, Andreansky M, Willert J, Shenoy S.

Biol Blood Marrow Transplant. 2019 Mar;25(3):556-561. doi: 10.1016/j.bbmt.2018.10.008. Epub 2018 Oct 12.

10.

Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis.

Gurunathan A, Boucher AA, Mark M, Prus KM, O'Brien MM, Breese EH, Mizukawa BE, Absalon MJ, Nelson AS, Jordan MB, Grimley MS, Lorsbach RB, Rotz SJ, Mathanda R, Kumar AR.

Pediatr Blood Cancer. 2018 Dec;65(12):e27400. doi: 10.1002/pbc.27400. Epub 2018 Oct 1.

PMID:
30272386
11.

Post-Transplant CD34+ Selected Stem Cell "Boost" for Mixed Chimerism after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation in Children and Young Adults with Primary Immune Deficiencies.

Chandra S, Bleesing JJ, Jordan MB, Grimley MS, Khandelwal P, Davies SM, Edwards S, Leemhuis T, Marsh RA.

Biol Blood Marrow Transplant. 2018 Jul;24(7):1527-1529. doi: 10.1016/j.bbmt.2018.03.013. Epub 2018 Mar 16.

12.

Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.

Shenoy S, Walters MC, Ngwube A, Soni S, Jacobsohn D, Chaudhury S, Grimley M, Chan K, Haight A, Kasow KA, Parikh S, Andreansky M, Connelly J, Delgado D, Godder K, Hale G, Nieder M, Pulsipher MA, Trachtenberg F, Neufeld E, Kwiatkowski JL, Thompson AA.

Biol Blood Marrow Transplant. 2018 Jun;24(6):1216-1222. doi: 10.1016/j.bbmt.2018.01.023. Epub 2018 Jan 31.

13.

Combination of High-Dose Methylprednisolone and Defibrotide for Veno-Occlusive Disease in Pediatric Hematopoietic Stem Cell Transplant Recipients.

Gloude NJ, Jodele S, Teusink-Cross A, Grimley M, Davies SM, Lane A, Myers KC.

Biol Blood Marrow Transplant. 2018 Jan;24(1):91-95. doi: 10.1016/j.bbmt.2017.09.007. Epub 2017 Sep 20.

14.

Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.

Khandelwal P, Teusink-Cross A, Davies SM, Nelson AS, Dandoy CE, El-Bietar J, Marsh RA, Kumar AR, Grimley MS, Jodele S, Myers KC.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1122-1127. doi: 10.1016/j.bbmt.2017.03.029. Epub 2017 Mar 23.

15.

Lower levels of vitamin A are associated with increased gastrointestinal graft-versus-host disease in children.

Lounder DT, Khandelwal P, Dandoy CE, Jodele S, Grimley MS, Wallace G, Lane A, Taggart C, Teusink-Cross AC, Lake KE, Davies SM.

Blood. 2017 May 18;129(20):2801-2807. doi: 10.1182/blood-2017-02-765826. Epub 2017 Mar 9.

16.

Team-based approach to identify cardiac toxicity in critically ill hematopoietic stem cell transplant recipients.

Dandoy CE, Jodele S, Paff Z, Hirsch R, Ryan TD, Jefferies JL, Cash M, Rotz S, Pate A, Taylor MD, El-Bietar J, Myers KC, Wallace G, Nelson A, Grimley M, Pfeiffer T, Lane A, Davies SM, Chima RS.

Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26513. Epub 2017 Mar 8.

PMID:
28271596
17.

Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation.

Lounder DT, Khandelwal P, Chandra S, Jordan MB, Kumar AR, Grimley MS, Davies SM, Bleesing JJ, Marsh RA.

Biol Blood Marrow Transplant. 2017 May;23(5):857-860. doi: 10.1016/j.bbmt.2017.02.011. Epub 2017 Feb 17.

18.

Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes.

Lee LH, Gasilina A, Roychoudhury J, Clark J, McCormack FX, Pressey J, Grimley MS, Lorsbach R, Ali S, Bailey M, Stephens P, Ross JS, Miller VA, Nassar NN, Kumar AR.

JCI Insight. 2017 Feb 9;2(3):e89473. doi: 10.1172/jci.insight.89473.

19.

Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.

Grimley MS, Chemaly RF, Englund JA, Kurtzberg J, Chittick G, Brundage TM, Bae A, Morrison ME, Prasad VK.

Biol Blood Marrow Transplant. 2017 Mar;23(3):512-521. doi: 10.1016/j.bbmt.2016.12.621. Epub 2017 Jan 5.

20.

Pericardial effusion requiring surgical intervention after stem cell transplantation: a case series.

Pfeiffer TM, Rotz SJ, Ryan TD, Hirsch R, Taylor M, Chima R, Pate A, Hlavaty J, Grimley M, Myers K, El-Bietar J, Davies SM, Jodele S, Dandoy C.

Bone Marrow Transplant. 2017 Apr;52(4):630-633. doi: 10.1038/bmt.2016.331. Epub 2016 Dec 19. No abstract available.

21.

Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

Walter JE, Rosen LB, Csomos K, Rosenberg JM, Mathew D, Keszei M, Ujhazi B, Chen K, Lee YN, Tirosh I, Dobbs K, Al-Herz W, Cowan MJ, Puck J, Bleesing JJ, Grimley MS, Malech H, De Ravin SS, Gennery AR, Abraham RS, Joshi AY, Boyce TG, Butte MJ, Nadeau KC, Balboni I, Sullivan KE, Akhter J, Adeli M, El-Feky RA, El-Ghoneimy DH, Dbaibo G, Wakim R, Azzari C, Palma P, Cancrini C, Capuder K, Condino-Neto A, Costa-Carvalho BT, Oliveira JB, Roifman C, Buchbinder D, Kumanovics A, Franco JL, Niehues T, Schuetz C, Kuijpers T, Yee C, Chou J, Masaad MJ, Geha R, Uzel G, Gelman R, Holland SM, Recher M, Utz PJ, Browne SK, Notarangelo LD.

J Clin Invest. 2016 Nov 1;126(11):4389. doi: 10.1172/JCI91162. Epub 2016 Nov 1. No abstract available.

22.

A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.

Khandelwal P, Emoto C, Fukuda T, Vinks AA, Neumeier L, Dandoy CE, El-Bietar J, Chandra S, Davies SM, Bleesing JJ, Jordan MB, Mehta PA, Jodele S, Grimley MS, Kumar A, Myers KC, Marsh RA.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2220-2225. doi: 10.1016/j.bbmt.2016.09.016. Epub 2016 Sep 21.

23.

Restrictive Palivizumab Use Does Not Lead to Increased Morbidity and Mortality in Pediatric Hematopoietic Stem Cell Transplantation Patients.

Teusink-Cross A, Davies SM, Danziger-Isakov L, El-Bietar J, Grimley MS.

Biol Blood Marrow Transplant. 2016 Oct;22(10):1904-1906. doi: 10.1016/j.bbmt.2016.07.005. Epub 2016 Jul 12.

24.

Erratum to "Bortezomib for Refractory Autoimmunity in Pediatrics" [Biol Blood Marrow Transplant 2014;20(10):1654-1659].

Khandelwal P, Davies SM, Grimley MS, Jordan MB, Curtis BR, Jodele S, Marsh R, Filipovich AH.

Biol Blood Marrow Transplant. 2016 Jun;22(6):1147. doi: 10.1016/j.bbmt.2015.11.014. Epub 2015 Nov 28. No abstract available.

25.

Effects of Diabetic Ketoacidosis on Visual and Verbal Neurocognitive Function in Young Patients Presenting with New-Onset Type 1 Diabetes.

Jessup AB, Grimley MB, Meyer E, Passmore GP, Belger A, Hoffman WH, Çalıkoğlu AS.

J Clin Res Pediatr Endocrinol. 2015 Sep;7(3):203-10. doi: 10.4274/jcrpe.2158.

26.

Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients.

Khandelwal P, Mellor-Heineke S, Rehman N, Lane A, Smiley K, Villanueva J, Marsh RA, Grimley MS, Davies SM, Filipovich AH.

Biol Blood Marrow Transplant. 2016 Apr;22(4):690-697. doi: 10.1016/j.bbmt.2015.12.016. Epub 2015 Dec 29.

27.

Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.

Walter JE, Rosen LB, Csomos K, Rosenberg JM, Mathew D, Keszei M, Ujhazi B, Chen K, Lee YN, Tirosh I, Dobbs K, Al-Herz W, Cowan MJ, Puck J, Bleesing JJ, Grimley MS, Malech H, De Ravin SS, Gennery AR, Abraham RS, Joshi AY, Boyce TG, Butte MJ, Nadeau KC, Balboni I, Sullivan KE, Akhter J, Adeli M, El-Feky RA, El-Ghoneimy DH, Dbaibo G, Wakim R, Azzari C, Palma P, Cancrini C, Capuder K, Condino-Neto A, Costa-Carvalho BT, Oliveira JB, Roifman C, Buchbinder D, Kumanovics A, Franco JL, Niehues T, Schuetz C, Kuijpers T, Yee C, Chou J, Masaad MJ, Geha R, Uzel G, Gelman R, Holland SM, Recher M, Utz PJ, Browne SK, Notarangelo LD.

J Clin Invest. 2015 Nov 2;125(11):4135-48. doi: 10.1172/JCI80477. Epub 2015 Oct 12. Erratum in: J Clin Invest. 2016 Nov 1;126(11):4389.

28.

Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies.

King AA, Kamani N, Bunin N, Sahdev I, Brochstein J, Hayashi RJ, Grimley M, Abraham A, Dioguardi J, Chan KW, Douglas D, Adams R, Andreansky M, Anderson E, Gilman A, Chaudhury S, Yu L, Dalal J, Hale G, Cuvelier G, Jain A, Krajewski J, Gillio A, Kasow KA, Delgado D, Hanson E, Murray L, Shenoy S.

Am J Hematol. 2015 Dec;90(12):1093-8. doi: 10.1002/ajh.24183. Epub 2015 Oct 6.

29.

Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen.

Marsh RA, Rao MB, Gefen A, Bellman D, Mehta PA, Khandelwal P, Chandra S, Jodele S, Myers KC, Grimley M, Dandoy C, El-Bietar J, Kumar AR, Leemhuis T, Zhang K, Bleesing JJ, Jordan MB, Filipovich AH, Davies SM.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1460-70. doi: 10.1016/j.bbmt.2015.04.009. Epub 2015 Apr 10.

30.

Successful Treatment of Disseminated Adenovirus Infection in an Infant With Acute Lymphoblastic Leukemia.

Alcamo AM, Pinchasik DE, Mo JQ, Grimley MS, O'Brien MM.

J Pediatr Hematol Oncol. 2015 Apr;37(3):e178-81. doi: 10.1097/MPH.0000000000000224.

PMID:
25089608
31.

Bortezomib for refractory autoimmunity in pediatrics.

Khandelwal P, Davies SM, Grimley MS, Jordan MB, Curtis BR, Jodele S, Marsh R, Filipovich AH.

Biol Blood Marrow Transplant. 2014 Oct;20(10):1654-9. doi: 10.1016/j.bbmt.2014.06.032. Epub 2014 Jun 28. Erratum in: Biol Blood Marrow Transplant. 2016 Jun;22(6):1147.

32.

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.

Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, Myers K, Grimley M, Bleesing J, El-Bietar J, Wallace G, Chima RS, Paff Z, Laskin BL.

Blood. 2014 Jul 24;124(4):645-53. doi: 10.1182/blood-2014-03-564997. Epub 2014 May 29.

33.

Secondary hemophagocytic lymphohistiocytosis (HLH) from a presumed brown recluse spider bite.

Dandoy C, Grimley M.

J Clin Immunol. 2014 Jul;34(5):544-7. doi: 10.1007/s10875-014-0036-1. Epub 2014 Apr 16.

PMID:
24737162
34.

The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients.

Khandelwal P, Lawrence J, Filipovich AH, Davies SM, Bleesing JJ, Jordan MB, Mehta P, Jodele S, Grimley MS, Kumar A, Myers K, Marsh RA.

Pediatr Transplant. 2014 Feb;18(1):94-102. doi: 10.1111/petr.12183. Epub 2013 Oct 30.

35.

Pediatric acute liver failure and immune dysregulation.

DiPaola F, Grimley M, Bucuvalas J.

J Pediatr. 2014 Feb;164(2):407-9. doi: 10.1016/j.jpeds.2013.10.044. Epub 2013 Dec 5. No abstract available.

PMID:
24315507
36.

An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.

Marsh RA, Kim MO, Liu C, Bellman D, Hart L, Grimley M, Kumar A, Jodele S, Myers KC, Chandra S, Leemhuis T, Mehta PA, Bleesing JJ, Davies SM, Jordan MB, Filipovich AH.

Biol Blood Marrow Transplant. 2013 Nov;19(11):1625-31. doi: 10.1016/j.bbmt.2013.09.001. Epub 2013 Sep 10.

37.

Challenges of disorders of sex development: diverse perceptions across stakeholders.

Kogan BA, Gardner M, Alpern AN, Cohen LM, Grimley MB, Quittner AL, Sandberg DE.

Horm Res Paediatr. 2012;78(1):40-6. doi: 10.1159/000339863. Epub 2012 Jul 20.

38.

Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).

Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S.

Biol Blood Marrow Transplant. 2012 Aug;18(8):1265-72. doi: 10.1016/j.bbmt.2012.01.019. Epub 2012 Feb 16.

39.

Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?

Fernandes JF, Rocha V, Labopin M, Neven B, Moshous D, Gennery AR, Friedrich W, Porta F, Diaz de Heredia C, Wall D, Bertrand Y, Veys P, Slatter M, Schulz A, Chan KW, Grimley M, Ayas M, Gungor T, Ebell W, Bonfim C, Kalwak K, Taupin P, Blanche S, Gaspar HB, Landais P, Fischer A, Gluckman E, Cavazzana-Calvo M; Eurocord and Inborn Errors Working Party of European Group for Blood and Marrow Transplantation.

Blood. 2012 Mar 22;119(12):2949-55. doi: 10.1182/blood-2011-06-363572. Epub 2012 Feb 3.

40.

Assessing health-related quality of life in disorders of sex development: phase I - item generation.

Sandberg DE, Gardner MD, Kogan BA, Grimley MB, Cohen L, Alpern AN, Quittner AL.

Adv Exp Med Biol. 2011;707:143-6. doi: 10.1007/978-1-4419-8002-1_31. No abstract available.

PMID:
21691973
41.

Parenting Stress among Parents of Deaf and Hearing Children: Associations with Language Delays and Behavior Problems.

Quittner AL, Barker DH, Cruz I, Snell C, Grimley ME, Botteri M; the CDaCI Investigative Team.

Parent Sci Pract. 2010 Apr 1;10(2):136-155.

42.

Engraftment of unrelated cord blood after reduced-intensity conditioning regimen in children with refractory neuroblastoma: a feasibility trial.

Jubert C, Wall DA, Grimley M, Champagne MA, Duval M.

Bone Marrow Transplant. 2011 Feb;46(2):232-7. doi: 10.1038/bmt.2010.107. Epub 2010 May 3.

PMID:
20436519
43.

Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.

Jacobson PA, Huang J, Wu J, Kim M, Logan B, Alousi A, Grimley M, Bolaños-Meade J, Ho V, Levine JE, Weisdorf D.

Biol Blood Marrow Transplant. 2010 Mar;16(3):421-9. doi: 10.1016/j.bbmt.2009.11.010.

44.

Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study.

Jacobsohn DA, Gilman AL, Rademaker A, Browning B, Grimley M, Lehmann L, Nemecek ER, Thormann K, Schultz KR, Vogelsang GB.

Blood. 2009 Nov 12;114(20):4354-60. doi: 10.1182/blood-2009-05-224840. Epub 2009 Sep 10.

PMID:
19745067
45.

A phase I/II study of the safety and efficacy of the addition of sirolimus to tacrolimus/methotrexate graft versus host disease prophylaxis after allogeneic haematopoietic cell transplantation in paediatric acute lymphoblastic leukaemia (ALL).

Pulsipher MA, Wall DA, Grimley M, Goyal RK, Boucher KM, Hankins P, Grupp SA, Bunin N.

Br J Haematol. 2009 Dec;147(5):691-9. doi: 10.1111/j.1365-2141.2009.07889.x. Epub 2009 Sep 10.

46.

Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313.

Pulsipher MA, Boucher KM, Wall D, Frangoul H, Duval M, Goyal RK, Shaw PJ, Haight AE, Grimley M, Grupp SA, Kletzel M, Kadota R.

Blood. 2009 Aug 13;114(7):1429-36. doi: 10.1182/blood-2009-01-196303. Epub 2009 Jun 15.

PMID:
19528536
47.

Prevalence and impact of depression in cystic fibrosis.

Quittner AL, Barker DH, Snell C, Grimley ME, Marciel K, Cruz I.

Curr Opin Pulm Med. 2008 Nov;14(6):582-8. doi: 10.1097/MCP.0b013e3283121cf1. Review.

PMID:
18812836
48.

Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia.

Chan KW, McDonald L, Lim D, Grimley MS, Grayson G, Wall DA.

Bone Marrow Transplant. 2008 Nov;42(9):589-95. doi: 10.1038/bmt.2008.227. Epub 2008 Aug 11.

PMID:
18695669
49.

Face emotion labeling deficits in children with bipolar disorder and severe mood dysregulation.

Rich BA, Grimley ME, Schmajuk M, Blair KS, Blair RJ, Leibenluft E.

Dev Psychopathol. 2008 Spring;20(2):529-46. doi: 10.1017/S0954579408000266.

50.

Early identification and management of graft failure after unrelated cord blood transplantation.

Chan KW, Grimley MS, Taylor C, Wall DA.

Bone Marrow Transplant. 2008 Jul;42(1):35-41. doi: 10.1038/bmt.2008.40. Epub 2008 Mar 10.

PMID:
18332909

Supplemental Content

Loading ...
Support Center